The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
Open accessAbstract
Significance: The effectiveness of nucleic acid drugs is limited by inefficient delivery to target tissues and cells and by unwanted accumulation in off-target organs. Although thousands of chemically distinct nanoparticles can be synthesized, nanoparticles designed to deliver nucleic acids in vivo were first tested in cell culture, yielding poor predictions for delivery in vivo. To facilitate testing of many nanoparticles in vivo, we designed and optimized a high-throughput DNA barcoding system to simultaneously measure nucleic acid delivery mediated by dozens of distinct nanoparticles in a single mouse. This nano-barcoding system can be used to study hundreds, or even thousands, of nanoparticles directly in vivo and could dramatically accelerate the discovery and understanding of nanoparticle drug delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dahlman et al. designed and optimized a high-throughput DNA barcoding system for the detection of lipid nanoparticles carrying specific nucleic acid barcodes in normal or tumor tissues in vivo, which facilitates the discovery of nanoparticles targeting tumor tissues and cells.339”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [339]
In the citing paper
“However, barcoded nanoparticles allow in vivo high-throughput profiling of lipid nanoparticle distribution at the cell level121.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Next-generation DNA sequencing
Shendure, J., & Ji, H. (2008) · Nature Biotechnology · doi:10.1038/nbt1486 · Cited by 4,509
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Self-citationBiomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Platt, R. J., Chen, S., Zhou, Y., Yim, M. J., Swiech, L., Kempton, H. R., Dahlman, J. E., Parnas, O., Eisenhaure, T. M., Jovanovic, M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.014 · Cited by 2,001
Self-citationRational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 5×
“study (12, 13, 27) in which liver-targeting siRNA-LNPs were formulated with 50% (14)C-labeled ionizable lipid, 10% DSPC, 38.”
BackgroundMethodInfluentialDelivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Self-citationModeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
PEGylated nanoparticles for biological and pharmaceutical applications
Otsuka, H., Nagasaki, Y., & Kataoka, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00226-0 · Cited by 1,619
Cited by
Sorted by citations
Items 301–331 of 331
A Quantitative Metal-Encoded Conjugate Platform for Targeting Ligand Discovery
Xu, Z., Huo, W., Ireland, T. J., Huang, L., Ocampo, T., & Vegas, A. J. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00195 · Cited by 1
Werfel, T. A. (2017) · Cited by 1
Navigating the Biological‐Material Interface with the Guide of Chemical Biology
Shieh, P. (2020) · ChemBioChem · doi:10.1002/cbic.202000529
Application of Artificial Intelligence for Designing Cancer Nanomedicine
Dilnawaz, F. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815050561122010005
Advancements in Translational Respiratory Research Using Nanotechnology
Bania, R., Borah, P., Devi, J. R., Deka, S., Dahabiyeh, L. A., Hourani, W., Deb, P. K., Venugopala, K. N., & Gupta, G. (2022) · Springer eBooks · doi:10.1007/978-981-16-4392-7_3
Pentafluorophenyl-based single-chain polymer nanoparticles
Paats, J.-W. D. (2023) · doi:10.3990/1.9789036557665
Future of Nanotechnology-Based Drug Discovery
Weerasinghe, L., Munaweera, I., & Kumarage, S. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238815124010008
Zanders, E. D. (2025) · Springer eBooks · doi:10.1007/978-3-031-93949-5_6 · Cited by 1
Customizing smart nano-vehicles for tumor therapy
Miao, Y. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33984-4.00002-x
Young, R. E., Vijayakumar, T., Reilley, L. J., Darji, K., Patel, D., Hofbauer, S. I., Alameh, M., Weissman, D., & Riley, R. (2026) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70114
Boyadjian, O., Ebrahimian, T., O'Connor, J. M., Rak, J. W., Lehoux, S., & Tabrizian, M. (2026) · Advanced Functional Materials · doi:10.1002/adfm.202526604
Crossing the barrier, crossing the line: neurotoxicity of nanomedicines in brain cancer therapy
Rochfort, K. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44579-8.00001-1
Ismail, R., Dhulkifle, H., Maayah, Z. H., Ebenazer, A., Alkilany, A. M., & Rachid, O. (2026) · Emergent Materials · doi:10.1007/s42247-026-01328-4
Navarro, I. B., Datto, G., Beni, L., Barragan, D., Mossburg, K. J., Shen, S., Hanna, A. R., Cormode, D. P., & Issadore, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.12.724546
Optimizing C14120-based lipid nanoparticles for mRNA delivery: Editorial commentary
Fung, V., Argenti, C., Magaw, M., & Fenton, O. S. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102945
Kehrein, J., Reus, E., Holick, C. T., Mummel, S., Ates, I., Wang, X., Hafke, M., Käsbach, J., Hoeppener, S., Weber, C., et al. (2026) · Journal of Controlled Release · doi:10.64898/2026.06.03.729611
Interactions between mRNA lipid nanoparticles and immune cells in fresh human whole blood
Hak, S., Rodà, F., Molska, A., Hernandez, F. D. C., Wolowczyk, C., Giambelluca, M. S., Glomm, W. R., Borgos, S. E., & Parot, J. (2026) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2026.115146
Niosomes: Nonionic surfactant-based system in breast cancer
Das, U., Bachhar, A., Barman, S., Sarkar, A., Bhardwaj, P., & Mandal, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43826-4.00003-8
Toh, W. H., Cheng, L., Chang, B., Yu, D., Ma, J., Huang, X., Weng, G., Zhu, Y., Lu, X., Lin, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.13.731774
Challenges and future horizons in nanomedicine
Sharma, C., Khan, A., Singh, S., Gautam, S., Potdar, P., & Scott, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36532-4.00012-2
Jiang, K., Shao, B., Li, R., Liang, T., You, C., Wang, L., Cen, J., Tan, J., Zhang, Y., Chen, M., et al. (2026) · Angewandte Chemie · doi:10.1002/ange.3823572
Hamilton, A. G., & Mitchell, M. J. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.103045
Spatial profiling of pooled mRNA-LNP delivery in vivo with NanoSTAMPPreprint
Zhu, Y., Yang, M., Anderson, I. J., Li, Y., Aghnatios, B., No, J., Ma, J., Yu, D., Wei, C., Lu, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.25.746710
Design of Chemically Programmable Nanomaterials for Organ-Selective Targeting
Zhu, S., Cai, W., & Tang, Z. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c09388
Barcoded oligonucleotide system (BOLT) for targeted organ delivery
Hou, X., Yu, C., Xue, Y., Liu, Y., Kang, D. D., Bennett, J. L., Bliss‐Moreau, E., Ni, M., Liu, Y., Fang, G., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.08.058
Vaidya, K., Karmaker, S., Boehnke, N., & Azarin, S. M. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c00526
Al-Hareth, Z., & López‐Camacho, C. (2026) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70183
González, C. C. (2026) · Nano Futures · doi:10.1088/2399-1984/aeb636
Zhang, P., Shao, J., Liang, Y., Li, Y., & Zhang, W. (2026) · Biophysica · doi:10.3390/biophysica6060104
Ahmadi, A., Refaat, A., Miao, K., Vidallon, M. L. P., McFadyen, J. D., Wang, X., & Peter, K. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115980
Smart nanomaterials for the delivery of gene editors: beyond LNPs
Guri, I., Benson, I., Kumar, P., & Jackow, J. (2026) · Frontiers in Nanotechnology · doi:10.3389/fnano.2026.1897092
Metadata
- Authors
- Dahlman, J. E., Kauffman, K. J., Xing, Y., Shaw, T. E., Mir, F. F., Dlott, C. C., Langer, R., Anderson, D. G., & Wang, E. T.
- Affiliations
- Georgia Institute of Technology (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- Harvard–MIT Division of Health Sciences and Technology (US)
- Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139;
- University of Florida (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-02-06
- Volume
- 114
- Issue
- 8
- Pages
- 2060-2065
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5338412
- OpenAlex
- W2586934391
- Cited by
- 335
- References
- 39
- Citations by year
- 2026: 50 · 2025: 62 · 2024: 53 · 2023: 43 · 2022: 40 · 2021: 22 · 2020: 24 · 2019: 13 · 2018: 18 · 2017: 10
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- HHS | National Institutes of Health (DP5-OD017865)
- National Science Foundation (1122374)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- nanoparticle biodistribution, siRNA delivery, structure-activity relationship
- MeSH terms
- Animals, Cell Separation, Pharmaceutical Preparations, Factor VII, Female, Flow Cytometry, Liver, Lung, Mice, Inbred C57BL, Nucleic Acids, Tissue Distribution, Drug Delivery Systems, RNA Interference, RNA, Small Interfering, Mice, Nanoparticles, Drug Discovery, DNA Barcoding, Taxonomic, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
